The expertise of health system specialty pharmacists, combined with better adherence and better affordability, leads to better patient outcomes.
Like pharmacists practicing in the community space, health system specialty pharmacists have a lot to offer patients when it comes to clinical care, according to Bill McElnea, vice president of population health at Shields Health Solutions.
“When we started in on this space, we weren’t exactly sure how the model was going to translate into these non-traditional spaces,” McElnea said, “but it translated very well.” Today, medication adherence rates are high across the Shields Health Solutions network: medication adherence rates within their diabetes programs are 90% proportion of days covered and the average medication copay is around $10, “which is a real game changer for clinics as well.”
In the diabetes space in particular, better adherence and better affordability taken together have resulted in an average 1-point reduction in hemoglobin A1c (HbA1c) across partner clinics. And within more at-risk populations, where clinics have dedicated ambulatory care pharmacist resources, HbA1c decreases of 2 points or higher are common—and are sustained over time.
McElnea sat down with Drug Topics at AXS24, the Asembia Specialty Pharmacy Summit, held April 28 to May 3 in Las Vegas, Nevada. Click here for more of our coverage from AXS24.
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.